Reviewing the amendment protocol of the AstraZeneca's fixed dose combination (FDC) Zibotentan plus Dapagliflozin, the Subject ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga (dapagliflozin) as an option to treat chronic ...

AstraZeneca's Farxiga reduced the risk of ... The study showed that treatment with Farxiga (dapagliflozin) led to an 18% reduction in cardiovascular death or worsening heart failure in patients ...

AstraZeneca’s legal challenge to Medicare ... and chronic kidney disease therapy Farxiga (dapagliflozin). The decision is an early win for the Biden administration in its defense of a series ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Oral antidiabetic drugs play an important role in the management of type 2 diabetes and were developed to regulate blood glucose levels in individuals who are resistant to the effects of insulin or ...